CRISPR for Biochemical Optimization

Introduction

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a genome editing technology that allows precise, efficient, and programmable modification of DNA in living organisms. Since its discovery as a bacterial immune system, CRISPR—particularly CRISPR-Cas9 and its derivatives—has revolutionized synthetic biology and metabolic engineering.

In biochemical optimization, CRISPR is used to rewire metabolic pathways, fine-tune gene expression, and enhance strain productivity in microorganisms. This leads to higher yields, reduced byproducts, and improved process stability for industrial production of biofuels, bioplastics, amino acids, antibiotics, enzymes, and other high-value chemicals.

What Products Are Produced?

CRISPR-aided strain engineering enhances production of:

• Biofuels: Ethanol, isobutanol, biodiesel precursors
• Bioplastics: PHB, PLA intermediates
• Amino acids: Lysine, glutamate, methionine
• Organic acids: Succinic, lactic, itaconic acids
• Enzymes & antibiotics: Industrial biocatalysts, erythromycin, streptomycin
• Alkaloids & terpenoids: Plant-derived pharmaceuticals and flavors

Pathways and Methods of Optimization

1. Gene Knockouts (CRISPR-Cas9)
• Disables competing pathways or undesirable genes to reroute metabolic flux toward target compounds.
2. CRISPR Activation (CRISPRa) and Interference (CRISPRi)
• Fine-tunes gene expression without cutting DNA; used for dynamic regulation of pathway genes.
3. Multiplex Genome Editing
• Edits multiple loci simultaneously to accelerate strain optimization.
4. Base Editing and Prime Editing
• Enables precise base conversions and insertions without double-stranded breaks, useful for delicate edits in essential genes.
5. CRISPR Screens
• High-throughput functional genomics for identifying gene targets in metabolic pathways.

Catalysts and Key Tools Used

• CRISPR-Cas Systems: Cas9, dCas9, Cas12a (Cpf1), Cas13 (RNA editing)
• Guide RNA Libraries: Custom gRNA arrays for multiplex pathway editing
• Delivery Platforms: Plasmid-based, electroporation, phage-assisted delivery in microbes
• Computational Tools: gRNA design software (e.g., CHOPCHOP, Benchling, CRISPy), flux balance analysis
• Host Organisms: E. coli, Saccharomyces cerevisiae, Corynebacterium glutamicum, Streptomyces, algae

Case Study: CRISPR-Enhanced Lactic Acid Production in Bacillus coagulans

Highlights

• Researchers used CRISPR-Cas9 to knock out lactate dehydrogenase (LDH) isozymes that caused racemic mixture formation.
• Engineered strain produced optically pure L-lactic acid—crucial for medical-grade PLA bioplastics.
• Further pathway optimization via CRISPRa improved glucose flux toward lactic acid.
• Achieved over 90 g/L yield with high productivity in fed-batch fermentation.

Timeline

• 2016 – Initial CRISPR editing of B. coagulans reported
• 2018 – Optically pure L-lactic acid strain developed
• 2021 – Integrated CRISPRi systems for pathway fine-tuning
• 2023 – Scale-up trials completed in China and South Korea for PLA markets

Global and Indian Startups Working in This Area

Global

• Ginkgo Bioworks (USA) – Uses CRISPR to optimize microbes for flavorings, fuels, and enzymes
• Zymergen (USA) – CRISPR-driven automation of bio-based material production
• Tropic Biosciences (UK) – CRISPR for high-value metabolites in plants and microbes
• Inscripta (USA) – Builds CRISPR-enabled strain engineering platforms

India

• String Bio (Bengaluru) – Uses CRISPR-based microbial platforms for single-cell protein and fine chemicals
• Sea6 Energy (Bengaluru) – CRISPR for improving metabolic outputs in marine microbes
• IGIB (New Delhi) & IISc Bengaluru – CRISPR for pathway engineering in biofuel-producing strains
• IIT Kharagpur & DBT – Applied CRISPR in metabolic models of Corynebacterium and Streptomyces

Market and Demand

The CRISPR-enabled biomanufacturing market is growing rapidly, estimated at USD 3.2 billion in 2023, projected to reach USD 8.5 billion by 2030 (CAGR of 14%).

Major End-Use Segments:

• Bio-based chemicals and fuels – Reduced cost, higher yield via engineered strains
• Pharmaceuticals – Antibiotics, biosimilars, plant alkaloid production
• Agri-biotech – Engineered soil microbes and plant-growth enhancers
• Industrial enzymes – Detergents, food processing, textile

Key Growth Drivers

• Fast, programmable, and cost-effective gene editing
• Reduced development time for optimized strains
• Integration with AI/ML and automation in strain design
• Surge in demand for custom biochemicals and green manufacturing
• Supportive global IP frameworks for CRISPR in industrial biotech

Challenges to Address

• Off-target effects: Risk of unintended mutations
• Strain instability: Some edits may impair long-term robustness
• Regulatory barriers: Especially for GMO strains in environmental or food applications
• Delivery challenges: Difficulties in transforming certain non-model microbes
• Scale-up reproducibility: Lab-optimized strains may underperform at pilot/commercial scale

Progress Indicators

• 2014 – CRISPR-Cas9 first applied in industrial microbes (E. coli, yeast)
• 2016 – CRISPRi/CRISPRa systems developed for dynamic control
• 2019 – Base editors introduced in Streptomyces and Corynebacterium
• 2022 – India’s DBT funds CRISPR-based strain engineering projects
• 2024 – Commercial launch of CRISPR-optimized PLA and amino acid strains

CRISPR-enabled strain optimization is at TRL 8–9 for model organisms and selected biochemicals, while applications in complex or non-model strains are at TRL 5–6.

Conclusion

CRISPR has emerged as a game-changing tool for the bioeconomy, accelerating the development of smart microbial factories for diverse biochemical production. With unmatched precision and speed, it’s transforming how we design and deploy microbes for industrial applications.

India’s expanding biotech landscape, strong academic base, and access to low-cost feedstocks offer a unique advantage in deploying CRISPR-based strain engineering to produce greener fuels, chemicals, and materials at scale.

Wish to have bio-innovations industry or market research support from specialists for climate & environment? Talk to BioBiz team – Call Muthu at +91-9952910083 or send a note to ask@biobiz.in